Breast Cancer-on-Chip for Patient-Specific Efficacy and Safety Testing of CAR-T Cells

Researchers developed a breast cancer-on-chip model with an integrated endothelial barrier that enables the transmigration of perfused immune cells, their infiltration into the tumor, and concomitant monitoring of cytokine release during perfused culture over a period of up to eight days.